CO2018001700A2 - Derivados de n-[1h-bencimidazol-2-il] metil-pirazin-2-il-carboxamida, composiciones y procedimientos de preparación de los mismos - Google Patents
Derivados de n-[1h-bencimidazol-2-il] metil-pirazin-2-il-carboxamida, composiciones y procedimientos de preparación de los mismosInfo
- Publication number
- CO2018001700A2 CO2018001700A2 CONC2018/0001700A CO2018001700A CO2018001700A2 CO 2018001700 A2 CO2018001700 A2 CO 2018001700A2 CO 2018001700 A CO2018001700 A CO 2018001700A CO 2018001700 A2 CO2018001700 A2 CO 2018001700A2
- Authority
- CO
- Colombia
- Prior art keywords
- benzimidazol
- pyrazin
- carboxamide
- derivatives
- compositions
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 4
- 239000003814 drug Substances 0.000 abstract 2
- 229940079593 drug Drugs 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4965—Non-condensed pyrazines
- A61K31/497—Non-condensed pyrazines containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C53/00—Saturated compounds having only one carboxyl group bound to an acyclic carbon atom or hydrogen
- C07C53/15—Saturated compounds having only one carboxyl group bound to an acyclic carbon atom or hydrogen containing halogen
- C07C53/16—Halogenated acetic acids
- C07C53/18—Halogenated acetic acids containing fluorine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/645—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
- C07F9/6503—Five-membered rings
- C07F9/6506—Five-membered rings having the nitrogen atoms in positions 1 and 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/645—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
- C07F9/6509—Six-membered rings
- C07F9/650952—Six-membered rings having the nitrogen atoms in the positions 1 and 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6558—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
- C07F9/65583—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system each of the hetero rings containing nitrogen as ring hetero atom
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Pulmonology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Otolaryngology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
La presente invención se refiere a los compuestos de la Fórmula (I): en donde R1, R2, R3 y Z- tienen uno de los significados que se indican en la memoria descriptiva, o una sal aceptable desde el punto de vista farmacéutico de aquellos, al uso de los compuestos de la Fórmula (I) como un medicamento, a una composición farmacéutica que comprende al menos un compuesto de la Fórmula (I), así como a combinaciones de medicamentos que contienen uno o más compuestos de la Fórmula (I).
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/EP2015/069152 WO2017028927A1 (en) | 2015-08-20 | 2015-08-20 | Novel annelated phenoxyacetamides |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CO2018001700A2 true CO2018001700A2 (es) | 2018-05-21 |
Family
ID=54065852
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CONC2018/0001700A CO2018001700A2 (es) | 2015-08-20 | 2018-02-20 | Derivados de n-[1h-bencimidazol-2-il] metil-pirazin-2-il-carboxamida, composiciones y procedimientos de preparación de los mismos |
Country Status (27)
| Country | Link |
|---|---|
| EP (1) | EP3298022B1 (es) |
| JP (1) | JP6620171B2 (es) |
| KR (1) | KR20180044333A (es) |
| CN (1) | CN108200769B (es) |
| AU (1) | AU2015406100B2 (es) |
| BR (1) | BR112018001035A2 (es) |
| CA (1) | CA2996087A1 (es) |
| CO (1) | CO2018001700A2 (es) |
| CY (1) | CY1122077T1 (es) |
| DK (1) | DK3298022T3 (es) |
| EA (1) | EA035738B1 (es) |
| ES (1) | ES2739893T3 (es) |
| HR (1) | HRP20191339T1 (es) |
| HU (1) | HUE046014T2 (es) |
| IL (1) | IL257136B (es) |
| LT (1) | LT3298022T (es) |
| ME (1) | ME03534B (es) |
| MX (1) | MX370598B (es) |
| MY (1) | MY194711A (es) |
| PH (1) | PH12018500378A1 (es) |
| PL (1) | PL3298022T3 (es) |
| PT (1) | PT3298022T (es) |
| RS (1) | RS59169B1 (es) |
| SA (1) | SA518390920B1 (es) |
| SI (1) | SI3298022T1 (es) |
| UA (1) | UA121414C2 (es) |
| WO (1) | WO2017028927A1 (es) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201610854D0 (en) | 2016-06-21 | 2016-08-03 | Entpr Therapeutics Ltd | Compounds |
| GB201619694D0 (en) | 2016-11-22 | 2017-01-04 | Entpr Therapeutics Ltd | Compounds |
| GB201717051D0 (en) | 2017-10-17 | 2017-11-29 | Enterprise Therapeutics Ltd | Compounds |
| GB201808093D0 (en) | 2018-05-18 | 2018-07-04 | Enterprise Therapeutics Ltd | Compounds |
| JP2023541601A (ja) | 2020-09-10 | 2023-10-03 | プレシリックス・ナームローゼ・ベンノートシヤープ | Ｆａｐに対する抗体フラグメント |
| WO2023203135A1 (en) | 2022-04-22 | 2023-10-26 | Precirix N.V. | Improved radiolabelled antibody |
| WO2023213801A1 (en) | 2022-05-02 | 2023-11-09 | Precirix N.V. | Pre-targeting |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2011079087A1 (en) * | 2009-12-23 | 2011-06-30 | Glaxo Group Limited | Enac blockers |
| WO2015007519A1 (en) * | 2013-07-15 | 2015-01-22 | Boehringer Ingelheim International Gmbh | Novel benzimidazolium compounds |
| EP3022198B1 (en) * | 2013-07-15 | 2019-09-11 | Boehringer Ingelheim International GmbH | Novel 5-substituted benzimidazolium compounds |
| JP6461133B2 (ja) * | 2013-07-15 | 2019-01-30 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | 新規４置換及び５置換ベンゾイミダゾリウム化合物 |
-
2015
- 2015-08-20 PT PT15760394T patent/PT3298022T/pt unknown
- 2015-08-20 CN CN201580083568.7A patent/CN108200769B/zh active Active
- 2015-08-20 JP JP2017564088A patent/JP6620171B2/ja active Active
- 2015-08-20 ES ES15760394T patent/ES2739893T3/es active Active
- 2015-08-20 DK DK15760394.5T patent/DK3298022T3/da active
- 2015-08-20 SI SI201530828T patent/SI3298022T1/sl unknown
- 2015-08-20 HU HUE15760394A patent/HUE046014T2/hu unknown
- 2015-08-20 EP EP15760394.5A patent/EP3298022B1/en active Active
- 2015-08-20 MX MX2018001945A patent/MX370598B/es active IP Right Grant
- 2015-08-20 BR BR112018001035-9A patent/BR112018001035A2/pt active Search and Examination
- 2015-08-20 CA CA2996087A patent/CA2996087A1/en not_active Abandoned
- 2015-08-20 LT LTEP15760394.5T patent/LT3298022T/lt unknown
- 2015-08-20 MY MYPI2018000198A patent/MY194711A/en unknown
- 2015-08-20 KR KR1020187007950A patent/KR20180044333A/ko unknown
- 2015-08-20 PL PL15760394T patent/PL3298022T3/pl unknown
- 2015-08-20 UA UAA201802620A patent/UA121414C2/uk unknown
- 2015-08-20 ME MEP-2019-247A patent/ME03534B/me unknown
- 2015-08-20 RS RSP20191100 patent/RS59169B1/sr unknown
- 2015-08-20 EA EA201890534A patent/EA035738B1/ru not_active IP Right Cessation
- 2015-08-20 WO PCT/EP2015/069152 patent/WO2017028927A1/en active Application Filing
- 2015-08-20 AU AU2015406100A patent/AU2015406100B2/en not_active Ceased
-
2018
- 2018-01-24 IL IL257136A patent/IL257136B/en unknown
- 2018-02-13 SA SA518390920A patent/SA518390920B1/ar unknown
- 2018-02-20 CO CONC2018/0001700A patent/CO2018001700A2/es unknown
- 2018-02-20 PH PH12018500378A patent/PH12018500378A1/en unknown
-
2019
- 2019-07-24 HR HRP20191339TT patent/HRP20191339T1/hr unknown
- 2019-09-05 CY CY20191100932T patent/CY1122077T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CO2018001700A2 (es) | Derivados de n-[1h-bencimidazol-2-il] metil-pirazin-2-il-carboxamida, composiciones y procedimientos de preparación de los mismos | |
| CO2018004857A2 (es) | Derivados de dihidroimidazopirazinona usados en el tratamiento del cáncer | |
| BR112018008880A8 (pt) | composto 7-(tiazol-5-il) pirrolopirimidina como agonista de tlr7 | |
| UY36112A (es) | Compuestos de imidazo[4,5-c]quinolin-2-ona y su uso para tratar cáncer | |
| BR112015021983A8 (pt) | compostos heterocíclicos, composições e usos dos mesmos | |
| BR112016010080A8 (pt) | compostos de pirazolopirimidina, composição farmacêutica e seu uso | |
| CL2013002417A1 (es) | Compuestos derivados de fluoropiridinona; composición farmacéutica que los comprende; y su uso en el tratamiento de infecciones bacterianas. | |
| BR112016011755A2 (pt) | derivado de ureia ou sal farmacologicamente aceitável do mesmo | |
| EA201990388A1 (ru) | Пиперидиновые модуляторы рецепторов cxcr7 | |
| PH12018500377A1 (en) | Novel annelated benzamides | |
| AR088622A1 (es) | 18-METIL-6,7-METILEN-3-OXO-17-PREGN-4-EN-21,17b-CARBOLACTONA, PREPARADOS FARMACEUTICOS QUE CONTIENEN LOS COMPUESTOS MENCIONADOS Y SU USO EN LA TERAPIA DE LA ENDOMETRIOSIS | |
| AR083879A1 (es) | Analogos de aminoglicosidos antibacterianos, metodos de preparacion y uso como agentes terapeuticos | |
| EA201690888A1 (ru) | Новые гетероциклические соединения | |
| BR112017009012A2 (pt) | derivados de anel benzo de seis membros como inibidor de dpp-4 e seu uso | |
| UY32674A (es) | Derivados heterociclicos de la urea y sus metodos de empleo | |
| PH12015502632A1 (en) | Cxcr7 receptor modulators | |
| BR112017026904A2 (pt) | formulações farmacêuticas injetáveis de lefamulina | |
| PE20210550A1 (es) | Compuestos de 4-metildihidropirimidinona y su uso farmaceutico | |
| MX368635B (es) | Compuestos tricíclicos de piperidina. | |
| UY32694A (es) | Derivados heterocíclicos de urea y métodos de uso de los mismos | |
| AR095032A1 (es) | Formulaciones de compuestos orgánicos, composición farmacéutica sólida comprimida por rodillo | |
| AR114418A1 (es) | Compuesto cíclico de metilactama y su utilización farmacéutica | |
| BR112016009214A8 (pt) | uso de um composto para preparação de um medicamento para o tratamento de distrofia muscular e composição farmacêutica | |
| EA201992804A1 (ru) | Производные аминогликозида и их применение при лечении генетических заболеваний | |
| CL2018000359A1 (es) | Fenoxiacetamidas apareadas novedosas |